埃利斯波特
免疫系统
医学
肝细胞癌
抗原
T细胞
表位
癌症研究
免疫学
作者
Eishiro Mizukoshi,Tatsuya Yamashita,Kuniaki Arai,Hajime Sunagozaka,Teruyuki Ueda,Fumitaka Arihara,Takashi Kagaya,Taro Yamashita,Kazumi Fushimi,Shuichi Kaneko
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2012-11-23
卷期号:57 (4): 1448-1457
被引量:269
摘要
Although RFA can enhance various TAA-specific T cell responses and the T cells induced contribute to the HCC recurrence-free survival of patients, besides immunosuppression by MDSCs, the memory phenotype and lifetime of TAA-specific T cells are not sufficient to prevent HCC recurrence completely. Additional treatments by vaccine or immunomodulatory drugs might be useful to improve the immunological effect of RFA.
科研通智能强力驱动
Strongly Powered by AbleSci AI